Literature DB >> 15090536

Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum.

Gábor Bánhegyi1, Angelo Benedetti, Rosella Fulceri, Silvia Senesi.   

Abstract

The functional coupling of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase was investigated in rat liver microsomal vesicles. The activity of both enzymes was latent in intact vesicles, indicating the intraluminal localization of their active sites. Glucose-6-phosphate, a substrate for hexose-6-phosphate dehydrogenase, stimulated the cortisone reductase activity of 11beta-hydroxysteroid dehydrogenase type 1. Inhibition of glucose-6-phosphate uptake by S3483, a specific inhibitor of the microsomal glucose-6-phosphate transporter, decreased this effect. Similarly, cortisone increased the intravesicular accumulation of radioactivity upon the addition of radiolabeled glucose-6-phosphate, indicating the stimulation of hexose-6-phosphate dehydrogenase activity. A correlation was shown between glucose-6-phosphate-dependent cortisone reduction and cortisone-dependent glucose-6-phosphate oxidation. The results demonstrate a close cooperation of the enzymes based on co-localization and the mutual generation of cofactors for each other.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090536     DOI: 10.1074/jbc.M404159200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.

Authors:  Deborah J Wake; Brian R Walker
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Contribution of hexose-6-phosphate dehydrogenase to NADPH content and redox environment in the endoplasmic reticulum.

Authors:  Daniela Rogoff; Kelli Black; D Randy McMillan; Perrin C White
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 3.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

4.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

5.  18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?

Authors:  Gianmario Sambuceti; Vanessa Cossu; Matteo Bauckneht; Silvia Morbelli; AnnaMaria Orengo; Sonia Carta; Silvia Ravera; Silvia Bruno; Cecilia Marini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05       Impact factor: 9.236

Review 6.  Minireview: endoplasmic reticulum stress: control in protein, lipid, and signal homeostasis.

Authors:  József Mandl; Tamás Mészáros; Gábor Bánhegyi; Miklós Csala
Journal:  Mol Endocrinol       Date:  2013-01-24

7.  Reduced cellular Mg²⁺ content enhances hexose 6-phosphate dehydrogenase activity and expression in HepG2 and HL-60 cells.

Authors:  Chesinta Voma; Andrew Barfell; Colleen Croniger; Andrea Romani
Journal:  Arch Biochem Biophys       Date:  2014-03-11       Impact factor: 4.013

8.  Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.

Authors:  Y Wang; Y Nakagawa; L Liu; W Wang; X Ren; A Anghel; K Lutfy; T C Friedman; Y Liu
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

9.  Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension.

Authors:  Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Maria Plonczynski; Celso E Gomez-Sanchez
Journal:  Exp Physiol       Date:  2009-10-16       Impact factor: 2.969

Review 10.  Rapid mechanisms of glucocorticoid signaling in the Leydig cell.

Authors:  Guo-Xin Hu; Qing-Quan Lian; Han Lin; Syed A Latif; David J Morris; Matthew P Hardy; Ren-Shan Ge
Journal:  Steroids       Date:  2007-12-28       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.